Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-PLAQUE trial
KCT0010331Phase 4Not yet recruiting
- Sponsor
- Yuhan
- Start
- Mar 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe, ulinastatin in coronary arteriosclerosis, sponsored by Yuhan. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
ezetimibeulinastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on KCT0010331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010331.